Medical Ikkou Group Co.,Ltd. (3353.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	55.0B	55.0B	48.4B	39.9B	33.9B
Cost of Revenue	11.8B	48.5B	42.6B	35.3B	30.7B
Gross Profit	1.6B	6.5B	5.7B	4.6B	3.2B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	1.1B	4.7B	4.1B	3.0B	2.2B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	1.1B	4.7B	4.1B	3.0B	2.2B
Cost and Expenses	53.2B	53.2B	46.7B	38.3B	33.0B
Operating Income (EBIT)	1.8B	1.8B	1.7B	1.6B	935.0M
Non-Operating
Interest Income	1.1M	15.7M	7.7M	1.6M	1.1M
Interest Expense	21.9M	102.7M	63.8M	54.0M	50.8M
Net Interest Income	(20.8M)	(87.0M)	(56.1M)	(52.4M)	(49.7M)
Other Non-Op Income/Expense	57.1M	71.0M	124.1M	192.7M	292.3M
Non-Operating Income (excl Interest)	97.6M	298.8M	227.0M	259.6M	350.4M
EBT (Pre-Tax Income)	665.8M	2.0B	1.9B	1.7B	1.3B
Income Tax Expense	212.0M	710.3M	754.5M	581.1M	540.5M
Bottom Line
Net Income	1.3B	1.3B	1.1B	1.0B	759.0M
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	1.3B	1.3B	1.1B	1.0B	759.0M
Per Share
Basic EPS	¥339	¥339	¥301	¥277	¥202
Diluted EPS	¥339	¥339	—	—	—
Revenue Per Share	¥14,606	¥14,606	¥12,870	¥10,618	¥9,023
Shares
Basic Shares Outstanding	3.8M	3.8M	3.8M	3.8M	3.8M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	2.5B	2.3B	2.2B	1.6B
D&A	—	722.5M	624.9M	612.8M	632.3M
EBIT	1.8B	1.8B	1.7B	1.6B	935.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Feb 1, 2026